Fluidic Multivalent Membrane Nanointerface Enables Synergetic Enrichment of Circulating Tumor Cells with High Efficiency and Viability.

The ubiquitous biomembrane interface, with its dynamic lateral fluidity, allows membrane-bound components to rearrange and localize for high-affinity multivalent ligand-receptor interactions in diverse life activities. Inspired by this, we herein engineered a fluidic multivalent nanointerface by decorating a microfluidic chip with aptamer-functionalized leukocyte membrane nanovesicles for high-performance isolation of circulating tumor cells (CTCs). This fluidic biomimetic nanointerface with active recruitment-binding affords significant affinity enhancement by four orders of magnitude, exhibiting 7-fold higher capture efficiency compared to a monovalent aptamer functionalized-chip in blood. Meanwhile, this soft nanointerface inherits the biological benefits of a natural biomembrane, min-imizing background blood cell adsorption and maintaining excellent CTC viability (97.6%). Using the chip, CTCs were successfully detected in all cancer patient samples tested (17/17), suggesting the high potential of this fluidity-enhanced multivalent strategy in clinical applications. We expect this bioengineered interface strategy will lead to the design of innovative biomimetic platforms in the biomedical field by leveraging natural cell-cell interaction with a natural biomaterial.

[1]  P. Cicuta,et al.  Programmable interactions with biomimetic DNA linkers at fluid membranes and interfaces , 2019, Reports on progress in physics. Physical Society.

[2]  Perry G. Schiro,et al.  Isolating Rare Cells and Circulating Tumor Cells with High Purity by Sequential eDAR. , 2019, Analytical chemistry.

[3]  Zhi Zhu,et al.  Isolation, Detection, and Antigen-Based Profiling of Circulating Tumor Cells Using a Size-Dictated Immunocapture Chip. , 2017, Angewandte Chemie.

[4]  X. Xia,et al.  Ultrasensitive Capture, Detection, and Release of Circulating Tumor Cells Using a Nanochannel-Ion Channel Hybrid Coupled with Electrochemical Detection Technique. , 2017, Analytical chemistry.

[5]  K. Pantel,et al.  Profiling circulating tumour cells and other biomarkers of invasive cancers , 2018, Nature Biomedical Engineering.

[6]  D. Hayes,et al.  A temporary indwelling intravascular aphaeretic system for in vivo enrichment of circulating tumor cells , 2019, Nature Communications.

[7]  Baoquan Ding,et al.  Tunable Rigidity of (Polymeric Core)–(Lipid Shell) Nanoparticles for Regulated Cellular Uptake , 2015, Advanced materials.

[8]  M. Toner,et al.  Enhanced Isolation and Release of Circulating Tumor Cells Using Nanoparticle Binding and Ligand Exchange in a Microfluidic Chip. , 2017, Journal of the American Chemical Society.

[9]  Woncheol Lee,et al.  Hydro-Seq enables contamination-free high-throughput single-cell RNA-sequencing for circulating tumor cells , 2019, Nature Communications.

[10]  N. Luo,et al.  Construction of a Biomimetic Magnetosome and Its Application as a SiRNA Carrier for High‐Performance Anticancer Therapy , 2018 .

[11]  Wei Wei,et al.  Biomimetic Immuno‐Magnetosomes for High‐Performance Enrichment of Circulating Tumor Cells , 2016, Advanced materials.

[12]  Yuqing Huang,et al.  DNA-mediated reversible capture and release of circulating tumor cells with a multivalent dual-specific aptamer coating network. , 2019, Chemical communications.

[13]  Crispin J. Miller,et al.  Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse , 2019, Nature Medicine.

[14]  J. Dai,et al.  Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis , 2019, Science Advances.

[15]  Waseem Asghar,et al.  Circulating tumor cell isolation, culture, and downstream molecular analysis. , 2018, Biotechnology advances.

[16]  Anne L. van de Ven,et al.  Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. , 2013, Nature nanotechnology.

[17]  K. Salaita,et al.  Ratiometric Tension Probes for Mapping Receptor Forces and Clustering at Intermembrane Junctions. , 2016, Nano letters.

[19]  Shutao Wang,et al.  Efficient Capture of Cancer Cells by Their Replicated Surfaces Reveals Multiscale Topographic Interactions Coupled with Molecular Recognition. , 2017, ACS applied materials & interfaces.

[20]  Evan W. Newell,et al.  TCR–peptide–MHC interactions in situ show accelerated kinetics and increased affinity , 2010, Nature.

[21]  Zuanguang Chen,et al.  A novel cytosensor for capture, detection and release of breast cancer cells based on metal organic framework PCN-224 and DNA tetrahedron linked dual-aptamer , 2019, Sensors and Actuators B: Chemical.

[22]  Baoquan Ding,et al.  Low-cost thermophoretic profiling of extracellular-vesicle surface proteins for the early detection and classification of cancers , 2019, Nature Biomedical Engineering.

[23]  Hui Chen,et al.  Intracellular hydrogelation preserves fluid and functional cell membrane interfaces for biological interactions , 2019, Nature Communications.

[24]  Amy E Herr,et al.  Profiling protein expression in circulating tumour cells using microfluidic western blotting , 2017, Nature Communications.

[25]  N. Palanisamy,et al.  Tunable Thermal‐Sensitive Polymer–Graphene Oxide Composite for Efficient Capture and Release of Viable Circulating Tumor Cells , 2016, Advances in Materials.

[26]  David J Mooney,et al.  Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T-cells , 2017, Nature Biotechnology.

[27]  Gao Yang,et al.  Multifunctional “Smart” Particles Engineered from Live Immunocytes: Toward Capture and Release of Cancer Cells , 2015, Advanced materials.

[28]  Jinsong Hu,et al.  Electrochemical Responsive Superhydrophilic Surfaces of Polythiophene Derivatives towards Cell Capture and Release. , 2018, Chemphyschem : a European journal of chemical physics and physical chemistry.

[29]  Ted T Lee,et al.  Multivalent Integrin-Specific Ligands Enhance Tissue Healing and Biomaterial Integration , 2010, Science Translational Medicine.

[30]  Xiaolei Zuo,et al.  DNA framework-programmed cell capture via topology-engineered receptor-ligand interactions. , 2019, Journal of the American Chemical Society.

[31]  Hai-Tao He,et al.  Dynamics in the plasma membrane: how to combine fluidity and order , 2006, The EMBO journal.

[32]  Yukui Zhang,et al.  Artificial Antibody with Site-Enhanced Multivalent Aptamers for Specific Capture of Circulating Tumor Cells. , 2019, Analytical chemistry.

[33]  D. Pang,et al.  Transformation of cell-derived microparticles into quantum-dot-labeled nanovectors for antitumor siRNA delivery. , 2015, Angewandte Chemie.

[34]  Jing Wang,et al.  Near-Infrared Light-Responsive Hydrogel for Specific Recognition and Photothermal Site-Release of Circulating Tumor Cells. , 2016, ACS nano.

[35]  Mark B. Carter,et al.  The Targeted Delivery of Multicomponent Cargos to Cancer Cells via Nanoporous Particle-Supported Lipid Bilayers , 2011, Nature materials.

[36]  H. Tseng,et al.  Covalent chemistry on nanostructured substrates enables noninvasive quantification of gene rearrangements in circulating tumor cells , 2019, Science Advances.

[37]  Weihong Tan,et al.  DNA probes for monitoring dynamic and transient molecular encounters on live cell membranes. , 2017, Nature nanotechnology.

[38]  W. Duan,et al.  Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture. , 2013, Analytical chemistry.

[39]  Jay T. Groves,et al.  Cluster size regulates protein sorting in the immunological synapse , 2009, Proceedings of the National Academy of Sciences.

[40]  Muling Shi,et al.  Aptasensor with Expanded Nucleotide Using DNA Nanotetrahedra for Electrochemical Detection of Cancerous Exosomes. , 2017, ACS nano.